European survey of cardiovascular disease prevention and diabetes (EuroAspire) - IV

European survey of cardiovascular disease prevention and diabetes (EuroAspire) - IV - EuroAspire-IV

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41357

Enrollment

715

Registered

2012-04-25

Start date

2012-07-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chestpain coronary heart disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - *18 years and

Exclusion criteria

Exclusion criteria: Patients admitted to hospital from outside the geographical area

Design outcomes

Primary

Measure	Time frame
To evaluate the proportions of hospital coronary patients and high risk individuals in primary care achieving European lifestyle, risk factors and therapeutic targets for cardiovascular disease prevention. The evaluate the management of risk in terms of lifestyle intervention and the use of drug therapies in relation to the lifestyle and therapeutic goals defined in the Vth European guidelines on cardiovascular disease prevention (2012).	—

Measure

Time frame

To evaluate the proportions of hospital coronary patients and high risk individuals in primary care achieving European lifestyle, risk factors and therapeutic targets for cardiovascular disease prevention. The evaluate the management of risk in terms of lifestyle intervention and the use of drug therapies in relation to the lifestyle and therapeutic goals defined in the Vth European guidelines on cardiovascular disease prevention (2012).

—

Secondary

Measure	Time frame
To evaluate cardiovascular events (non-fatal coronary and cardiovascular events, including revascularisation and hospitalisations, and cardiovascular/total mortality)	—

Countries

Netherlands

Outcome results